steviol glycoside/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on systolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Meta-analysis revealed a non-significant difference in systolic blood pressure between steviol glycoside and placebo, mean difference (MD): -2.98 mm Hg (-6.23 to 0.27).”
Quoted verbatim from Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: a systematic review and meta-analysis of randomised clinical trials.. - Study
- meta-analysis
- Population
- Participants in nine randomised trials of stevioside or rebaudioside A (756 participants overall), most at high cardiovascular risk
Effect -2.98 mean difference, 95% CI -6.23 to 0.27
Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: a systematic review and meta-analysis of randomised clinical trials.2015PMID:25412840Permalink
Keep reading
- Everything the graph holds on steviol glycoside
- Every compound studied against Systolic blood pressure (setting unspecified)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PPRN9MG6F7AR22SASCNJMB